Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Edmund Huang, Stanley C. Jordan
Abstract
Nearly 10 months after the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the virus responsible for coronavirus disease 2019 (Covid-19), therapeutic options remai...
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusMedicine2019-20 coronavirus outbreakVirologyBetacoronavirusCoronavirus InfectionsDiseaseIntensive care medicineInternal medicineInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19